“…Similarly, episomal vector delivery of Oct4, Sox2, Klf4, Lin28, and L-Myc in combination with histone deacetylase inhibitor treatment has converted pig fibroblasts into induced neural progenitor cells [120] , and Oct4, Sox2, Klf4, and small hairpin RNA-p53 with a cocktail of small molecules has converted human fibroblasts into induced neural stem cells [119] , however no conversion efficiencies were reported for either study. Interestingly, a secondary system enabling non-viral neural direct conversion has been reported, in which fibroblasts, liver cells, and B lymphocytes were isolated from chimeric mice carrying inducible vectors expressing Brn2, Hes1, Hes3, Klf4, c-Myc, Plagl1, Notch1 (NICD), and Rfx4, with subsequent conversion into induced neural stem cells following transgene induction, however again with no reported conversion efficiencies [99] . Overall, while some nonviral methods achieve conversion efficien cies similar to studies utilising viral vectors [147] , others achieve considerably lower conversion efficiencies [98,112] or have not reported them [99,119,120] , thus necessitating optimisation of non-viral methods in order for them to become a viable alternative.…”